Free Facing criticism from academic oncologists, Imbruvica’s makers bring back low-dose pill May 18, 2018Vol.44 No.20By Paul Goldberg
Conversation with The Cancer LetterFree Olive: It’s true, gynecologists don’t biopsy masses as much as other surgeons May 18, 2018Vol.44 No.20By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Yale’s Desai: Gynecologists must preoperatively workup and discuss the risks, benefits, alternatives May 18, 2018Vol.44 No.20By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Fox Chase’s Rubin: Don’t morcellate and you won’t have to worry about cutting up missed cancers May 18, 2018Vol.44 No.20By Matthew Bin Han Ong
Conversation with The Cancer LetterFree OU’s Mannel: Gynecologists must thoroughly evaluate postmenopausal women for hidden cancers May 18, 2018Vol.44 No.20By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Vanderbilt’s Alvarez: Gynecologists must properly assess all patients for cancer before surgery May 18, 2018Vol.44 No.20By Matthew Bin Han Ong
Free Gynecology’s deadly surprise:Cancers are frequently missed prior to routine procedures May 18, 2018Vol.44 No.20By Matthew Bin Han Ong
FreeSatireTrials & Tribulations The imaginary interview(with apologies to Molière, aka Jean-Baptiste Poquelin) May 11, 2018Vol.44 No.19By Derek Raghavan
FreeObituary Jane Reese-Coulbourne, advocate, consultant, industry executive, dies at 63 May 11, 2018Vol.44 No.19
Conversation with The Cancer LetterFree BMS’s Saha: We’re at the start of defining new endpoints, hypotheses with real-world evidence May 04, 2018Vol.44 No.18By Matthew Bin Han Ong
